Peptides,
without the hype.
From insulin and GLP-1s to BPC-157, melanocortins, and the longevity-clinic frontier — taught with claim-grading, FDA-status clarity, and three learner tracks for every clinician.
Choose your depth
Switch tracks anytime in the sidebar. Lessons adapt — patient summaries, clinician summaries, and advanced notes appear based on your selection.
Foundational peptide pharmacology, terminology, and the regulatory landscape — for any clinician.
Indications, dosing, monitoring, contraindications, and clinical reasoning for prescribers.
Receptor pharmacology, trial design, pipeline molecules, and frontier research for specialists.
11 modules unlocked
This is not another "longevity peptides will save you" course.
Insulin, semaglutide, leuprolide and oxytocin are peptides — and so are BPC-157, MOTS-c and the dozens of compounds the FDA placed on category 2 in 2023. We teach the difference using evidence grades and explicit regulatory tiers, so you always know what's established, what's promising, and what's marketing.